Hi all,

We recently implemented the use of 503(b) compounded phenylephrine syringes for increased safety in our perioperative settings but are encountering concerns from our Billing team.

They are referencing that CDC and CMS guidelines for SDV's specifically say you cannot share Single Dose Vials (SDV) with multiple patients and because these vials were made from SDV at the compounder we may not be reimbursed for them when used in the Periop/ED settings. Also, that their use could even jeopardize the reimbursement of an entire OR case.